<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://novapharmanews.com/apac/news/pmda-approves-enhertu-for-her2-low-breast-cancer-in-japan</loc>
    <lastmod>2026-06-10T22:25:52.592Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>NovaPharmaNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-10T22:17:07.203Z</news:publication_date>
      <news:title>PMDA approves ENHERTU for HER2-low breast cancer in Japan</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://novapharmanews.com/us/news/fda-salmonella-moringa-leaf-powder-recall-january-2026</loc>
    <lastmod>2026-06-10T23:38:44.222Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>NovaPharmaNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-09T08:05:43.896Z</news:publication_date>
      <news:title>FDA investigates Salmonella in moringa leaf powder, expands recall</news:title>
      <news:keywords>Salmonella</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://novapharmanews.com/uploads/articles/fda-salmonella-moringa-leaf-powder-recall-january-2026.webp</image:loc>
      <image:title>FDA investigates Salmonella in moringa leaf powder, expands recall</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://novapharmanews.com/eu/news/krx-ir-reference-s896010510626060808350-scd-ndr-eng-jun-2026</loc>
    <lastmod>2026-06-10T21:51:39.629Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>NovaPharmaNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-06-09T02:30:45.616Z</news:publication_date>
      <news:title>KRX IR Reference : Executive Summary Plan for SCD NDR (ENG, Jun 2026)</news:title>
      <news:keywords>ISENTRESS, raltegravir, Apretude, Biktarvy</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://novapharmanews.com/uploads/articles/krx-ir-reference-s896010510626060808350-scd-ndr-eng-jun-2026.webp</image:loc>
      <image:title>KRX IR Reference : Executive Summary Plan for SCD NDR (ENG, Jun 2026)</image:title>
    </image:image>
  </url>
</urlset>